American Life Sciences Innovation Council
@ALSICinnovation
Followers
69
Following
19
Media
1
Statuses
197
ALSIC is a social welfare organization created in 2010 to support policies that foster an environment in which medical innovation can thrive.
Joined July 2019
RT @FDAOncology: In case you missed it: FDA & FDAOncology, patients, @ASCO @RareDiseases @IAmBiotech & others discussed the Accelerated App….
0
1
0
RT @statnews: Gilead Sciences said that a large clinical trial of its drug Trodelvy achieved its primary goal of delaying tumor growth in w….
0
2
0
RT @CardiologyToday: Bayer announced that asundexian, a novel factor XIa inhibitor being evaluated for secondary prevention of #stroke, has….
healio.com
Bayer announced that asundexian, a novel factor XIa inhibitor being evaluated for secondary prevention of stroke, has received fast track designation from the FDA. The drug is being studied for...
0
1
0
RT @FDAOncology: #FDA Approval Summary: Abemaciclib With Endocrine Therapy for High-Risk Early Breast Cancer. This summary presents FDA's a….
ascopubs.org
PURPOSEThe US Food and Drug Administration approved abemaciclib in combination with endocrine therapy (ET) for the adjuvant treatment of adult patients with hormone receptor–positive, human epidermal...
0
4
0
RT @BioCalifornia: CROs embracing tech to decentralize trials and speed enrollment as regulators show support 'with their feet' https://t.c….
0
1
0
RT @WRALTechWire: Targeting rare diseases: Inside Durham biotech startup's latest deal #WRALTechWire
wraltechwire.com
The acquisition comes after Kriya landed a whopping $100 million in capital in 2021. That’s on top of $80.5 million raised in 2020.
0
2
0
RT @ncbio: The government price-fixing scheme moving through Congress poses a grave danger to innovation, and in particular, the scientific….
mercurynews.com
Drug-pricing caps in the the president’s Build Back Better Act would destroy financial incentives for innovation.
0
1
0
RT @DrugChannels: Mind blowing margins: #Hospitals markup CAR-T by 300%+ over WAC. Even at lowest #340B discounts, #hospitals absorb ~2/3 o….
0
18
0
RT @AIMatMelanoma: FDA Approves Merck’s KEYTRUDA® (pembrolizumab) as Adjuvant Treatment for Adult and Pediatric (≥12 Years of Age) Patients….
0
2
0
RT @biogen: Today, in partnership with @SageBiotech, we announced interim data from the open-label Phase 3 SHORELINE Study designed to foll….
0
2
0
RT @DanaFarberNews: Rounding out #PancreaticCancer awareness month with a look at advances in treatment and detection of this disease cc @c….
0
6
0
RT @NCSTI: Congrats to @Arrevus, a @NCCommerce #OneNCSmallBiz grantee, on their recent acquisition. This acquisition by @aceragen builds….
0
2
0
RT @AstraZeneca: In a new @NatureComms paper we found where #Cardiomyocytes – the cells that make our hearts contract – proliferate, and sh….
0
10
0
RT @BayerPharma: We are sharing the excitement!.Huma and @Bayer will use #machinelearning in this research project to accelerate diagnosis….
0
6
0
RT @PharmaTimes: FDA approves Exelixis’ Cabometyx for differentiated thyroid cancer #lifesciences #pharma.
0
1
0
RT @VertexPharma: Vertex announces publication in @NEJM of a #Phase3 study evaluating one of our #cysticfibrosis medicines. Read more in to….
0
1
0
RT @AbbottNews: The recent FDA approval for our minimally invasive Amplatzer Amulet provides new options for a common heart condition known….
abbott.com
Abbott receives FDA approval for Amplatzer Amulet and Portico with FlexNav devices, solidifying its structural heart portfolio as the most comprehensive in U.S.
0
4
0
RT @genentech: #Breaking: Today we announced Phase III topline results from a trial evaluating our regimen against the standard of care for….
gene.com
Discover the latest news about our company, our products, our policies, and our people.
0
3
0